Clinical Trial Update: Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing high (150 mg) versus standard (75 mg) clopidogrel in diabetic patients with NSTEMI undergoing coronary angioplasty, assessing incidenc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-segment Elevation Myocardial Infarction
• Type 2 Diabetes Mellitus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Laboratoires Teriak | Conditions: Diabetes Mellitus, Type 2, NSTEMI - Non-ST Segment Elevation MI | Phase 4 | Status: COMPLETED